FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1605185781> ?p ?o ?g. }

• W1605185781 endingPage "43" @default.
• W1605185781 startingPage "35" @default.
• W1605185781 abstract "Abstract Introduction Vaginal dryness due to vaginal atrophy is a common complaint of postmenopausal women, interfering with sexual function and quality of life. Hormone replacement therapy is the only effective therapy but with known risks that leave unmet medical needs. A new product, ZP-025 vaginal gel, containing purified (dialyzed lyophilized) bovine colostrum, has been developed for the treatment of vaginal dryness secondary to vaginal atrophy. Aim The study aims to investigate the effects of intravaginal application of ZP-025 on vaginal atrophy using an animal model. Methods Ovariectomized female Sprague-Dawley rats were used. Three weeks after surgery, rats were divided into four groups and treated for 4 weeks (twice a day) with placebo or ZP-025 at low (0.5%) or high (2.3%) concentrations of colostrum; in the control group, rats did not receive any treatment. Changes in vaginal blood flow due to pelvic nerve stimulation were assessed by laser Doppler flowmetry and vaginal tissue was collected for histological assay. Main Outcome Measures The main outcome measures were vaginal blood flow before and after pelvic nerve stimulation and histology of vaginal epithelium. Results Treatment with ZP-025 to ovariectomized rats induced an increase of vaginal blood flow parameters (vascular capacitance, amplitude and area under the curve of the response) in response to pelvic nerve stimulation compared with control group, statistically significant at 2.3%. Vaginal epithelium showed a physiological estrous cycle aspect in treated animals, with at least five cell layers vs. one or two cell layers in control rats. As expected from a topical formulation, systemic effects on body weights and uterine wet weights were not observed with application of ZP-025. Conclusions In this study, the new product ZP-025, containing purified colostrum, was shown to have beneficial effects on vaginal atrophy in ovariectomized rats, improving vaginal hemodynamics and thickness of vaginal epithelium." @default.
• W1605185781 created "2016-06-24" @default.
• W1605185781 creator A5045590829 @default.
• W1605185781 creator A5052655299 @default.
• W1605185781 creator A5053070403 @default.
• W1605185781 creator A5061204912 @default.
• W1605185781 creator A5073616887 @default.
• W1605185781 date "2013-12-01" @default.
• W1605185781 modified "2023-09-26" @default.
• W1605185781 title "Evaluation of the Effects of a New Intravaginal Gel, Containing Purified Bovine Colostrum, on Vaginal Blood Flow and Vaginal Atrophy in Ovariectomized Rat" @default.
• W1605185781 cites W1552052892 @default.
• W1605185781 cites W1554016331 @default.
• W1605185781 cites W1572920143 @default.
• W1605185781 cites W1796167402 @default.
• W1605185781 cites W1970025509 @default.
• W1605185781 cites W1976411950 @default.
• W1605185781 cites W1978750198 @default.
• W1605185781 cites W1983021641 @default.
• W1605185781 cites W1992039191 @default.
• W1605185781 cites W1994129791 @default.
• W1605185781 cites W1998186825 @default.
• W1605185781 cites W2002470627 @default.
• W1605185781 cites W2011900238 @default.
• W1605185781 cites W2016665864 @default.
• W1605185781 cites W2034879381 @default.
• W1605185781 cites W2037738117 @default.
• W1605185781 cites W2041699365 @default.
• W1605185781 cites W2052253052 @default.
• W1605185781 cites W2053764026 @default.
• W1605185781 cites W2069249560 @default.
• W1605185781 cites W2074852079 @default.
• W1605185781 cites W2080826159 @default.
• W1605185781 cites W2096927328 @default.
• W1605185781 cites W2099702361 @default.
• W1605185781 cites W2123580528 @default.
• W1605185781 cites W2125454133 @default.
• W1605185781 cites W2135338977 @default.
• W1605185781 cites W2137385430 @default.
• W1605185781 cites W2142851752 @default.
• W1605185781 cites W2161969697 @default.
• W1605185781 cites W2161987170 @default.
• W1605185781 cites W2175765352 @default.
• W1605185781 cites W2222541464 @default.
• W1605185781 cites W4231317556 @default.
• W1605185781 doi "https://doi.org/10.1002/sm2.8" @default.
• W1605185781 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4184496" @default.
• W1605185781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25356286" @default.
• W1605185781 hasPublicationYear "2013" @default.
• W1605185781 type Work @default.
• W1605185781 sameAs 1605185781 @default.
• W1605185781 citedByCount "8" @default.
• W1605185781 countsByYear W16051857812016 @default.
• W1605185781 countsByYear W16051857812017 @default.
• W1605185781 countsByYear W16051857812019 @default.
• W1605185781 countsByYear W16051857812022 @default.
• W1605185781 countsByYear W16051857812023 @default.
• W1605185781 crossrefType "journal-article" @default.
• W1605185781 hasAuthorship W1605185781A5045590829 @default.
• W1605185781 hasAuthorship W1605185781A5052655299 @default.
• W1605185781 hasAuthorship W1605185781A5053070403 @default.
• W1605185781 hasAuthorship W1605185781A5061204912 @default.
• W1605185781 hasAuthorship W1605185781A5073616887 @default.
• W1605185781 hasBestOaLocation W16051857811 @default.
• W1605185781 hasConcept C126322002 @default.
• W1605185781 hasConcept C134018914 @default.
• W1605185781 hasConcept C141071460 @default.
• W1605185781 hasConcept C158846371 @default.
• W1605185781 hasConcept C2776917545 @default.
• W1605185781 hasConcept C2777744392 @default.
• W1605185781 hasConcept C2778723060 @default.
• W1605185781 hasConcept C2781172350 @default.
• W1605185781 hasConcept C71315377 @default.
• W1605185781 hasConcept C71924100 @default.
• W1605185781 hasConcept C8264082 @default.
• W1605185781 hasConceptScore W1605185781C126322002 @default.
• W1605185781 hasConceptScore W1605185781C134018914 @default.
• W1605185781 hasConceptScore W1605185781C141071460 @default.
• W1605185781 hasConceptScore W1605185781C158846371 @default.
• W1605185781 hasConceptScore W1605185781C2776917545 @default.
• W1605185781 hasConceptScore W1605185781C2777744392 @default.
• W1605185781 hasConceptScore W1605185781C2778723060 @default.
• W1605185781 hasConceptScore W1605185781C2781172350 @default.
• W1605185781 hasConceptScore W1605185781C71315377 @default.
• W1605185781 hasConceptScore W1605185781C71924100 @default.
• W1605185781 hasConceptScore W1605185781C8264082 @default.
• W1605185781 hasIssue "2" @default.
• W1605185781 hasLocation W16051857811 @default.
• W1605185781 hasLocation W16051857812 @default.
• W1605185781 hasLocation W16051857813 @default.
• W1605185781 hasLocation W16051857814 @default.
• W1605185781 hasOpenAccess W1605185781 @default.
• W1605185781 hasPrimaryLocation W16051857811 @default.
• W1605185781 hasRelatedWork W2049176839 @default.
• W1605185781 hasRelatedWork W2079034779 @default.
• W1605185781 hasRelatedWork W2086596628 @default.
• W1605185781 hasRelatedWork W2124447873 @default.
• W1605185781 hasRelatedWork W2163611543 @default.
• W1605185781 hasRelatedWork W2364319574 @default.

• next